CAS No. |
3521-62-8 |
中文名称 |
(2S,3R,4S,6R)-4-(二甲氨基)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-乙基-7,12,13-三羟基-4-(((2R,4R,5S,6S)-5-羟基-4-甲氧基-4,6-二甲基四氢-2H-吡喃-2-基)氧基)-3,5,7,9,11,13-六甲基-2,10-二氧代氧杂环十四烷-6-基)氧基)-6-甲基四氢-2H-吡喃-3-基丙酸酯十二烷基硫酸盐 |
英文名称 |
(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl propionate dodecyl sulfate |
别名 |
eritroger;eromycin;erythromycin,propionate(ester),compd.withmonododecylsulfate(1:1);erythromycin5-(3-propionate)dodecylsulfate;erythromycinpropionate,compd.withdodecylsulfate;erythromycinpropionatelaurylsulfate;ERYTHROMYCIN ESTOLATE;ERYTHROMYCIN 2'-PROPANOATE DODECYL SULFATE SALT |
标准英文名 |
(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl propionate dodecyl sulfate |
分子式 |
C40H71NO14.C12H26O4S |
分子量 |
1055.64
|
精确分子量 |
1055.64
|
SMILES |
CCC(O[C@H]([C@H](C[C@H](O1)C)N(C)C)[C@@H]1O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H](C([C@@H](C[C@]2(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)O)OC)C)=O.CCCCCCCCCCCCOS(=O)(O)=O |
标准SMILES |
CO[C@]1(C)C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]1[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@H]1C.CCCCCCCCCCCCOS(O)(=O)=O |
用途 |
Erythromycin estolate is used clinically as an alternative to penicillin in patients with penicillin allergy for the treatment of infections caused by susceptible organisms, including:
- Streptococcus pyogenes and Streptococcus pneumoniae (e.g., acute tonsillitis, pharyngitis, sinusitis);
- Streptococcus pyogenes (e.g., scarlet fever, cellulitis);
- Corynebacterium diphtheriae (diphtheria and carrier state);
- Clostridium perfringens (gas gangrene), Bacillus anthracis (anthrax), Clostridium tetani (tetanus);
- Actinomycosis;
- Syphilis;
- Listeriosis.
It exhibits antibacterial activity against Staphylococcus spp., Streptococcus spp., and other Gram-positive bacilli. It is also active against Neisseria spp., Haemophilus influenzae, Bordetella pertussis, most anaerobes (except Bacteroides fragilis and Fusobacterium spp.), Legionella pneumophila, Campylobacter fetus, certain spirochetes, Mycoplasma pneumoniae, Rickettsia spp., and Chlamydia spp.
Erythromycin estolate is primarily bacteriostatic but may be bactericidal at high concentrations. It is specifically indicated for penicillin-resistant and penicillin-allergic Staphylococcus aureus infections. |
InChIKey |
AWMFUEJKWXESNL-JZBHMOKNSA-N |